Greggory Davis v. HHS - Influenza, Guillain-Barré Syndrome (GBS) (2023)

Greggory Davis filed a petition for compensation under the National Vaccine Injury Compensation Program, alleging that he suffered Guillain-Barré Syndrome (GBS) as a result of an influenza vaccine he received on October 13, 2020. The respondent conceded that Mr.

Davis's GBS met the criteria set forth in the Vaccine Injury Table and the Qualifications and Aids to Interpretation for GBS following flu vaccination. Consequently, a ruling on entitlement was issued on July 29, 2022, finding Mr.

Davis entitled to compensation. Subsequently, on November 14, 2023, a decision awarding damages was issued.

The parties agreed to a proffer of compensation, which included a lump sum payment of $584,311.07. This amount covered life care expenses for the first year ($87,565.07), past and future lost wages ($216,046.00), pain and suffering ($250,000.00), and past unreimbursable expenses ($30,700.00).

Additionally, an amount was awarded to purchase an annuity contract for future life care expenses. The case proceeded as a Table claim, and the outcome was compensation for Mr.

Davis.